Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT06783127

Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer

Sponsor: Santa Chiara Hospital

View on ClinicalTrials.gov

Summary

This is an observational, retrospective/prospective, multicenter study designed to define, overall survival, clinical outcomes and predictive/prognostic factors of a consecutive population of mCRPC patients treated with olaparib in clinical practice.

Official title: Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer: An Observational Study

Key Details

Gender

MALE

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

3000

Start Date

2023-01-01

Completion Date

2026-12-31

Last Updated

2025-02-11

Healthy Volunteers

Conditions

Prostate Cancer Castrate Resistant Prostate Cancer BRCA Mutation

Interventions

DRUG

Olaparib

Olaparib given according the clinical practice to BRCA positive mCRPC patients

Locations (2)

Sabrina Rossetti

Naples, Italy

Orazio Caffo

Trento, Italy